Content
Frontiers of Medicine >> 2023, Volume 17, Issue 4 doi: 10.1007/s11684-022-0972-8
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy
Abstract
Keywords
anti-CD19 chimeric antigen receptor T ; immunotherapy ; diffuse large B cell lymphoma ; tumor microenvironment ; tumor-associated macrophage ; metabolism
Content